EE04495B1 - Meetod antikolinergikum tiotroopiumbromiidi valmistamiseks - Google Patents

Meetod antikolinergikum tiotroopiumbromiidi valmistamiseks

Info

Publication number
EE04495B1
EE04495B1 EEP200300309A EEP200300309A EE04495B1 EE 04495 B1 EE04495 B1 EE 04495B1 EE P200300309 A EEP200300309 A EE P200300309A EE P200300309 A EEP200300309 A EE P200300309A EE 04495 B1 EE04495 B1 EE 04495B1
Authority
EE
Estonia
Prior art keywords
preparation
tiotropium bromide
anticholinergic
anticholinergic tiotropium
bromide
Prior art date
Application number
EEP200300309A
Other languages
English (en)
Estonian (et)
Inventor
Banholzer Rolf
Ludwig August Graulich Manfred
Luettke Sven
Mathes Andreas
Meissner Helmut
Specht Peter
Broeder Wolfgang
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7668836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04495(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300309A publication Critical patent/EE200300309A/xx
Publication of EE04495B1 publication Critical patent/EE04495B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
EEP200300309A 2000-12-22 2001-12-12 Meetod antikolinergikum tiotroopiumbromiidi valmistamiseks EE04495B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064816A DE10064816A1 (de) 2000-12-22 2000-12-22 Verfahren zur Herstellung eines Anticholinergikums
PCT/EP2001/014566 WO2002051840A1 (de) 2000-12-22 2001-12-12 Verfahren zur herstellung des anticholinergikums tiotropiumbromid

Publications (2)

Publication Number Publication Date
EE200300309A EE200300309A (et) 2003-10-15
EE04495B1 true EE04495B1 (et) 2005-06-15

Family

ID=7668836

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300309A EE04495B1 (et) 2000-12-22 2001-12-12 Meetod antikolinergikum tiotroopiumbromiidi valmistamiseks

Country Status (42)

Country Link
US (1) US6486321B2 (es)
EP (2) EP1426373B1 (es)
JP (1) JP4198991B2 (es)
KR (1) KR100853109B1 (es)
CN (2) CN100393719C (es)
AR (1) AR033599A1 (es)
AT (2) ATE266661T1 (es)
AU (1) AU2002229650B2 (es)
BG (1) BG66373B1 (es)
BR (1) BRPI0116444B8 (es)
CA (1) CA2433518C (es)
CY (1) CY1105210T1 (es)
CZ (1) CZ294958B6 (es)
DE (3) DE10064816A1 (es)
DK (2) DK1345936T3 (es)
EA (1) EA005533B1 (es)
EC (1) ECSP034652A (es)
EE (1) EE04495B1 (es)
EG (1) EG23914A (es)
ES (2) ES2271722T3 (es)
HK (2) HK1060570A1 (es)
HR (1) HRP20030502B1 (es)
HU (1) HU230320B1 (es)
IL (2) IL156351A0 (es)
ME (1) MEP40608A (es)
MX (1) MXPA03005426A (es)
MY (1) MY129525A (es)
NO (1) NO327739B1 (es)
NZ (1) NZ527066A (es)
PE (1) PE20020755A1 (es)
PL (1) PL202478B1 (es)
PT (2) PT1345936E (es)
RS (1) RS50271B (es)
SA (1) SA01220589B1 (es)
SI (1) SI1345936T1 (es)
SK (1) SK287318B6 (es)
TR (1) TR200401127T4 (es)
TW (1) TWI234564B (es)
UA (1) UA74409C2 (es)
UY (1) UY27079A1 (es)
WO (1) WO2002051840A1 (es)
ZA (1) ZA200304707B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
EP1292281B1 (de) * 2000-10-12 2004-09-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue tiotropium-haltige inhalationspulver
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US6852728B2 (en) 2000-10-14 2005-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
KR100971616B1 (ko) * 2001-06-22 2010-07-22 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 결정질 항콜린제, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7405224B2 (en) * 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7311894B2 (en) * 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
NZ536277A (en) * 2002-04-04 2006-03-31 Boehringer Ingelheim Pharma Powder formulations containing tiotropium suitable for inhalation
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
SI1682541T1 (sl) * 2003-11-03 2010-06-30 Boehringer Ingelheim Int Postopek za pripravo tiotropijevih soli
EP2083007B1 (de) * 2003-11-03 2013-04-24 Boehringer Ingelheim International Gmbh Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
AU2006243239A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
SI1881980T1 (sl) * 2005-05-02 2012-12-31 Boehringer Ingelheim International Gmbh Nove kristalinične oblike tiotropijevega bromida
NZ564697A (en) * 2005-06-15 2010-04-30 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
CN1316245C (zh) * 2005-07-28 2007-05-16 山东齐都药业有限公司 托烷司琼合成中残留中间体托品醇的检测方法
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
DE102005059602A1 (de) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
TW200734333A (en) * 2005-12-19 2007-09-16 Sicor Inc Pure and stable tiotropium bromide
KR101395881B1 (ko) * 2005-12-19 2014-05-21 시코르, 인크. 브롬화 티오트로피움의 신규한 형태 및 이의 제조 방법
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
CN100410254C (zh) * 2006-03-07 2008-08-13 南昌弘益科技有限公司 噻托溴铵无水物制备方法
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
EP1882691A1 (en) * 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Quinuclidine derivatives as M3 antagonists
EP1950196A1 (de) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Ammoniumhexafluorophosphaten
EP2036898A2 (de) * 2007-09-13 2009-03-18 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von 1,3-Dioxolan-2Onen sowie von Carbonsäureestern durch Transacylierung unter Basischen Reaktionsbedingungen
PL2240477T3 (pl) * 2008-01-10 2015-03-31 Generics Uk Ltd Nowy sposób wytwarzania estrów skopiny
WO2011015884A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
JP5822831B2 (ja) 2009-08-07 2015-11-24 ジェネリクス・［ユーケー］・リミテッド チオトロピウム臭化物の無水物
CN101768158B (zh) * 2010-01-04 2013-05-29 南昌弘益科技有限公司 噻托溴铵无水物及其制备方法
CN101863885B (zh) * 2010-06-03 2012-05-30 南京金丹呈医药技术有限公司 一种噻托溴铵的制备方法
TR201007108A2 (tr) * 2010-08-25 2012-03-21 B�Lg�� Mahmut Yeni tiotropyum bromür kristali ve üretim yöntemi.@
ITRM20110508A1 (it) 2011-09-27 2013-03-28 Lusochimica Spa Processo per la preparazione degli esteri della scopina.
RS55996B1 (sr) * 2011-12-22 2017-09-29 Cerbios-Pharma S A Kontinuirani postupak za alkilaciju cikličnih tercijarnih amina
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
CZ305012B6 (cs) * 2012-03-30 2015-03-25 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu
CA2907566C (en) 2013-04-01 2023-08-22 Pulmatrix, Inc. Tiotropium dry powders
WO2018055642A1 (en) * 2016-09-23 2018-03-29 Gbr Laboratories Pvt. Ltd. A process for preparing tiotropium bromide and intermediates thereof
WO2019129801A1 (en) 2017-12-28 2019-07-04 Linnea S.A. Process for the purification of methyl-2,2-dithienylglycolate
CN113264929B (zh) * 2021-05-02 2023-10-10 润生药业有限公司 一种噻托溴铵的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
HUP0301457A3 (en) 2006-05-29
EA200300666A1 (ru) 2003-12-25
SK9352003A3 (en) 2003-10-07
ES2271722T3 (es) 2007-04-16
UY27079A1 (es) 2002-07-31
HU230320B1 (hu) 2016-01-28
HK1060570A1 (en) 2004-08-13
NO20032827D0 (no) 2003-06-20
PL202478B1 (pl) 2009-06-30
MEP40608A (en) 2011-02-10
KR20030062439A (ko) 2003-07-25
CN1481383A (zh) 2004-03-10
CY1105210T1 (el) 2010-03-03
MXPA03005426A (es) 2005-04-20
HK1096683A1 (en) 2007-06-08
ZA200304707B (en) 2004-04-20
ATE266661T1 (de) 2004-05-15
EG23914A (en) 2007-12-30
PT1426373E (pt) 2006-11-30
KR100853109B1 (ko) 2008-08-21
CZ20031685A3 (cs) 2003-10-15
EP1345936A1 (de) 2003-09-24
EP1345936B1 (de) 2004-05-12
HUP0301457A2 (hu) 2003-10-28
BG107910A (bg) 2004-02-27
NO20032827L (no) 2003-06-20
SK287318B6 (sk) 2010-07-07
JP4198991B2 (ja) 2008-12-17
AU2002229650B2 (en) 2006-12-21
BRPI0116444B8 (pt) 2021-05-25
YU50903A (sh) 2006-05-25
US20020133010A1 (en) 2002-09-19
WO2002051840A1 (de) 2002-07-04
CN1244581C (zh) 2006-03-08
CZ294958B6 (cs) 2005-04-13
EA005533B1 (ru) 2005-04-28
CN100393719C (zh) 2008-06-11
EP1426373A1 (de) 2004-06-09
HRP20030502A2 (en) 2005-04-30
TWI234564B (en) 2005-06-21
EP1426373B1 (de) 2006-08-23
TR200401127T4 (tr) 2004-07-21
US6486321B2 (en) 2002-11-26
PT1345936E (pt) 2004-09-30
ECSP034652A (es) 2003-07-25
PL361837A1 (en) 2004-10-04
CA2433518A1 (en) 2002-07-04
BR0116444A (pt) 2003-12-23
NO327739B1 (no) 2009-09-14
CN1840529A (zh) 2006-10-04
RS50271B (sr) 2009-07-15
EE200300309A (et) 2003-10-15
SI1345936T1 (en) 2004-08-31
DE10064816A1 (de) 2002-06-27
ES2221658T3 (es) 2005-01-01
PE20020755A1 (es) 2002-09-24
UA74409C2 (uk) 2005-12-15
IL156351A0 (en) 2004-01-04
HRP20030502B1 (en) 2011-09-30
JP2004525099A (ja) 2004-08-19
DE50102299D1 (de) 2004-06-17
CA2433518C (en) 2007-03-20
DK1426373T3 (da) 2006-12-18
AR033599A1 (es) 2003-12-26
NZ527066A (en) 2004-12-24
IL156351A (en) 2011-09-27
ATE337314T1 (de) 2006-09-15
DE50110835D1 (de) 2006-10-05
SA01220589B1 (ar) 2006-10-31
BRPI0116444B1 (pt) 2015-09-01
BG66373B1 (bg) 2013-10-31
DK1345936T3 (da) 2004-07-19
MY129525A (en) 2007-04-30

Similar Documents

Publication Publication Date Title
EE200300309A (et) Meetod antikolinergikum tiotroopiumbromiidi valmistamiseks
AU2002229650A1 (en) Method for producing the anticholinergic agent tiotropium bromide
DK1326862T3 (da) Krystallinsk monohydrat af tiotropiumbromid, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel
EG24851A (en) Crystalline anticholinergic process for the preparation thereof for preparing a medicament
EE200200656A (et) Ravis kasutatavad tropaani derivaadid
EE05179B1 (et) Ravimitena kasutatavad antikolinergikumid ning meetod nende valmistamiseks
EP1343481A4 (en) PROCESS FOR THE PREPARATION OF A QUICKLY SOLUBLE DOSAGE FORM
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20032518D0 (no) Fremgangsmåte for fremstilling av amlodipinmaleat
NO20023950D0 (no) Fremgangsmåte for fremstilling av en titanholdig zeolitt
DE60233709D1 (de) Ausnehmmechanismus einer Hohlglasformmaschine
EE200400045A (et) Tehniline sünteesimeetod tropenooli valmistamiseks
NO20023973D0 (no) Fremgangsmåte for fremstilling av en titanholdig zeolitt
DE60233549D1 (de) Ausnehmmechanismus einer Hohlglasformmaschine
HK1048112B (zh) 3-乙烯基-頭孢化合物的製備方法
NO20031911D0 (no) Inhalasjonslösningsformulering med et tiotropiumsalt
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
FI20011034A (fi) Menetelmä absorboivien aineiden valmistamiseksi
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
NO324220B1 (no) Fremgangsmate for fremstilling av en polymorf
EE200300204A (et) Meetod distamütsiini derivaadi valmistamiseks
FI20010927A (fi) Menetelmä terapeuttisesti aktiivisen yhdisteen valmistamiseksi
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20025385D0 (no) FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter
NO20032707D0 (no) Ny fremgangsmåte for fremstilling av diaryl-4- aminopiperidinylforbindelser

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20141212